Neutralizing activity of Sputnik V vaccine sera against SARS-CoV-2 variants

The novel pandemic betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has infected at least 120 million people since its identification as the cause of a December 2019 viral pneumonia outbreak in Wuhan, China(1,2). Despite the unprecedented pace of vaccine development, wi...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Res Sq
Egile Nagusiak: Ikegame, Satoshi, Siddiquey, Mohammed N. A., Hung, Chuan-Tien, Haas, Griffin, Brambilla, Luca, Oguntuyo, Kasopefoluwa Y., Kowdle, Shreyas, Vilardo, Ariel Esteban, Edelstein, Alexis, Perandones, Claudia, Kamil, Jeremy P., Lee, Benhur
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Journal Experts 2021
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC8043464/
https://ncbi.nlm.nih.gov/pubmed/33851150
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21203/rs.3.rs-400230/v1
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak